Table 3.
Comparison of documented PMP assessments and activities over 2 years
| High-dose group (n = 60) | Traditional dose group (n = 60) | P value | |
|---|---|---|---|
| Average number of visits to PMP | 6.9 (4.9) | 5.3 (2.7) | 0.022 |
| Assessed for | |||
| Functional status | 80.0% (48) | 78.3% (47) | 0.822 |
| Depression | 91.7% (55) | 95.0% (57) | 0.464 |
| Anxiety | 88.3% (53) | 90.0% (54) | 0.769 |
| Substance use/abuse | 88.3% (53) | 95.0% (57) | 0.186 |
| Psychosocial stressors | 65.0% (39) | 63.3% (38) | 0.849 |
| Activities conducted | |||
| Prescribed non-opioid medication for pain | 45.0% (27) | 65.0% (39) | 0.028 |
| Rotated opioid prescription | 23.0% (14) | 18.3% (11) | 0.500 |
| Tapered opioid prescription dose | 28.3% (17) | 11.7% (7) | 0.022 |
| Administered urine drug screen | 45.0% (27) | 20.0% (12) | 0.003 |
| Discussed side effects of opioid prescription | 41.7% (25) | 51.7% (31) | 0.272 |
| Considered a non-pharmacological approach | 71.7% (43) | 67.0% (40) | 0.553 |
| Patient participated in non-pharmacological approach | 50.0% (30) | 50.0% (30) | 1.000 |
| Collaborated with mental health provider | 38.3% (23) | 40.0% (24) | 0.852 |
| Consulted with a pain specialist | 31.7% (19) | 23.3% (14) | 0.307 |
| Developed a pain goal | 48.3% (29) | 20.0% (12) | 0.001 |
Column values indicate % (n) for categorical variables or mean ± standard deviation for continuous variables.